Abstract
Owing to the serious clinical consequences associated with acquisition of resistance to current antiretroviral drugs, discovery of new drug targets and development of novel anti-HIV-1 therapeutic agents have become a high research priority. The late stages of HIV-1 replication involve the processes of assembly, budding and maturation, and comprise several new potential therapeutic targets which have not (yet) been targeted by any of the antiretroviral drugs approved at present. The structural protein Gag plays a central role in these stages through its different regions and mature Gag proteins working in concert. In this article, we highlight a number of steps in the late stages of HIV-1 replication that represent promising targets for drug discovery. Recent progress in development of related inhibitors targeting at CA, zinc fingers of NC, p6-Tsg101 interaction, lipid rafts of plasma membrane, proteolytic cleavage sites in Gag and gp160 processing is also reviewed.
Keywords: HIV-1, assembly, budding, maturation, Gag, Matrix, Nucleocapsid, Capsid, immunodeficiency, causative agent, UNAIDS/WHO, Epidemic, vaccine, drug, antiretroviral, viral replication cycle, noninfectious, polyprotein, cytoplasmic, RNA genome, capsid antigen, glycoprotein, encapsidation, multimerization, hexameric lattice, mutations, zinc-finger, globular structure, virus infectivity, myristic acid, phospholipids, phosphatidylinositol, acyl chain, antiviral, ribosomes, multivesicular bodys, amino-acid, high-resolution structural, peptides, enzymes, rational drug, silicon, spectroscopy, hydrophobic cavity, isolates, Inhibitors, glycineamide, cyclophilin, oxygen, isoxazole, sulfamide, binding affinity, disulfide bond, half-life, reduction, solubility, cell toxicity, covalent, bioavailability, aromatic ring, tryptophan, secondary screening, Betulinic Acid Derivatives, dimethylsuccinyl, drug-resistant HIV-1, virology
Current Medicinal Chemistry
Title: New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle
Volume: 18 Issue: 1
Author(s): Yan Jiang, Xinyong Liu and Erik De Clercq
Affiliation:
Keywords: HIV-1, assembly, budding, maturation, Gag, Matrix, Nucleocapsid, Capsid, immunodeficiency, causative agent, UNAIDS/WHO, Epidemic, vaccine, drug, antiretroviral, viral replication cycle, noninfectious, polyprotein, cytoplasmic, RNA genome, capsid antigen, glycoprotein, encapsidation, multimerization, hexameric lattice, mutations, zinc-finger, globular structure, virus infectivity, myristic acid, phospholipids, phosphatidylinositol, acyl chain, antiviral, ribosomes, multivesicular bodys, amino-acid, high-resolution structural, peptides, enzymes, rational drug, silicon, spectroscopy, hydrophobic cavity, isolates, Inhibitors, glycineamide, cyclophilin, oxygen, isoxazole, sulfamide, binding affinity, disulfide bond, half-life, reduction, solubility, cell toxicity, covalent, bioavailability, aromatic ring, tryptophan, secondary screening, Betulinic Acid Derivatives, dimethylsuccinyl, drug-resistant HIV-1, virology
Abstract: Owing to the serious clinical consequences associated with acquisition of resistance to current antiretroviral drugs, discovery of new drug targets and development of novel anti-HIV-1 therapeutic agents have become a high research priority. The late stages of HIV-1 replication involve the processes of assembly, budding and maturation, and comprise several new potential therapeutic targets which have not (yet) been targeted by any of the antiretroviral drugs approved at present. The structural protein Gag plays a central role in these stages through its different regions and mature Gag proteins working in concert. In this article, we highlight a number of steps in the late stages of HIV-1 replication that represent promising targets for drug discovery. Recent progress in development of related inhibitors targeting at CA, zinc fingers of NC, p6-Tsg101 interaction, lipid rafts of plasma membrane, proteolytic cleavage sites in Gag and gp160 processing is also reviewed.
Export Options
About this article
Cite this article as:
Jiang Yan, Liu Xinyong and De Clercq Erik, New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication Cycle, Current Medicinal Chemistry 2011; 18 (1) . https://dx.doi.org/10.2174/092986711793979751
DOI https://dx.doi.org/10.2174/092986711793979751 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Determinants of Paraoxonase 1 Status: Genes, Drugs and Nutrition
Current Medicinal Chemistry Deubiquitinating Enzymes as Therapeutic Targets in Cancer
Current Pharmaceutical Design Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology Role of Chymase in Preeclampsia
Current Vascular Pharmacology Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Current Genomics in Cardiovascular Medicine
Current Genomics Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Absolute Quantification of Human Uridine-Diphosphate Glucuronosyl Transferase (UGT) Enzyme Isoforms 1A1 and 1A6 By Tandem LC-MS
Drug Metabolism Letters Oxidative Stress in the Hypothalamus: the Importance of Calcium Signaling and Mitochondrial ROS in Body Weight Regulation
Current Neuropharmacology Computational Models of Neuronal Biophysics and the Characterization of Potential Neuropharmacological Targets
Current Medicinal Chemistry Antioxidant Profile of Hyaluronan: Physico-Chemical Features and its Role in Pathologies
Mini-Reviews in Medicinal Chemistry The Role of the Calcium-Sensing Receptor in Human Pathophysiology
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Biological Ageing, Inflammation and Nutrition: How Might They Impact on Systemic Sclerosis?
Current Aging Science Medial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry Reviews Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Growth Plate Cartilage as Developmental Model in Osteoarthritis Research -Potentials and Limitations
Current Drug Targets